Janssen Search
Search results
Leveraging a Pathway Approach to help Restore Balance to the Immune System
Leveraging a Pathway Approach to Help Restore Balance to the Immune System Janssen is committed to leveraging a pathway approach to help restore balance to the immune system, which in people living with autoimmune diseases responds by attacking healthy ...
Commercialization of Cardiovascular Treatment
Commercialization Bringing transformational care and treatment options to patients. At Janssen, our worldwide commercial entities are working to market and ensure access to medicines in more than 175 countries. We have success rates in securing approvals, ...
Nick Pineda
In his role of Chief of Staff of the Janssen Human Microbiome Institute (JHMI), Nick is responsible for the execution and operationalization of the JHMI strategy. This includes implementing key systems and processes needed to establish a growth portfolio ...
Science of Immorbidity
2 nd International Symposium, 12 October 2017: The Science of Immorbidity- New Approaches to Prevention in Creating a World Without Disease About the Symposium The word immorbidity describes a state where a person is able to evade the diseases that ...
Jane Kielt
The Art of Getting Lost Janssen proudly features artwork created by people affected by the illnesses and diseases that we are dedicated to helping prevent and treat. Please visit our art gallery to learn more about the artists and view more artwork. Jane ...
Living with PAH
Living with Pulmonary Arterial Hypertension (PAH) PAH is a rare, progressive disease that currently has no cure. The immediate goal is to prolong survival whilst improving the quality of life for those living with the disease. To achieve these goals, ...
Mark Oswald
Mark Oswald brings more than twenty years of combined technical leadership, software development, program and product management and technology consulting experience. At Janssen Healthcare Innovation (JHI), Mark is responsible for leading the global ...
Advancing the Power of Monoclonal Antibodies
Advancing the Power and Promise of Monoclonal Antibodies Janssen was one of the first companies to recognize the diagnostic and therapeutic potential of monoclonal antibodies, and today we are continuing to apply that expertise to explore their power and ...
Cardiovascular, Metabolism & Retina
Cardiovascular, Metabolism & Retina At Janssen Cardiovascular, Metabolism (CVM) & Retina, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing ...
Health Management for Women
Collaboration with the International Partnership for Microbicides Women and girls, particularly in sub-Saharan Africa where the HIV epidemic has hit hardest, remain particularly vulnerable to infection. New HIV prevention tools are needed to empower women ...